Lataa...
Treatment of relapsed and refractory multiple myeloma
The therapeutic strategy for relapsed and refractory multiple myeloma (RRMM) integrates a holistic approach regarding patient, disease, and drug-related factors. Patient-related factors include age, frailty status, and underlying comorbidities, especially cardiovascular and renal diseases and periph...
Tallennettuna:
| Julkaisussa: | Blood Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386890/ https://ncbi.nlm.nih.gov/pubmed/32719176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2020.S008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|